Total revenues (USD, millions)

Cost of sales, excluding amortization of intangibles (USD, millions)

Selling, marketing and administrative (USD, millions)

Research and development (USD, millions)

Amortization of intangible assets (USD, millions)

Integration related costs (USD, millions)

Goodwill impairment charge (USD, millions)

Asset impairment charge (USD, millions)

Other operating expenses (USD, millions)

Operating income (loss) (USD, millions)

Interest expense, net (USD, millions)

Other expense, net (USD, millions)

Loss before income taxes (USD, millions)

Provision for (benefit from) income taxes (USD, millions)

Net loss (USD, millions)

Basic loss per share (USD)

Diluted loss per share (USD)

Weighted-average shares outstanding - basic (Shares, millions)

Weighted-average shares outstanding - diluted (Shares, millions)

0a7f2ba0dcbb7b78166ba0804842a362a98a7453afc65247a20ac69e827dbcdd

Cash and cash equivalents (USD, millions)

Marketable securities, current (USD, millions)

Accounts receivable, net (USD, millions)

Inventories (USD, millions)

Prepaid expenses and other current assets (USD, millions)

Assets held for sale (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Marketable securities, non-current (USD, millions)

Right-of-use assets (USD, millions)

Goodwill (USD, millions)

Intangible assets, net (USD, millions)

Deferred tax assets (USD, millions)

Other assets (USD, millions)

Total assets (USD, millions)

Accounts payable (USD, millions)

Accrued payroll and related expenses (USD, millions)

Income tax payable (USD, millions)

Current portion of borrowings (USD, millions)

Other current liabilities (USD, millions)

Total current liabilities (USD, millions)

Operating lease liabilities (USD, millions)

Long-term borrowings (USD, millions)

Deferred tax liabilities (USD, millions)

Other liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock, $0.001 par value per share (USD, millions)

Additional paid-in capital (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Retained earnings (USD, millions)

Total stockholders’ equity (USD, millions)

Total liabilities and stockholders’ equity (USD, millions)

3fa318bd31a3172adc2d3e5ac76571894bc543547aa6016a3c69953c92123830

North America

EMEA

China

Other

Total Revenue

c92ba184fb6ab203669ceadc73ef012ee7fd41ea317060d042a61856ec136937

Net loss (In millions)

Depreciation and amortization (In millions)

Goodwill impairment charge (In millions)

Stock-based compensation expense (In millions)

Net change in operating lease right-of-use assets and liabilities (In millions)

Change in deferred tax assets and liabilities (In millions)

Payment of accreted interest on deferred consideration (In millions)

Other non-cash, net (In millions)

Changes in assets and liabilities: Accounts receivable (In millions)

Changes in assets and liabilities: Inventories (In millions)

Changes in assets and liabilities: Prepaid expenses and other current and non-current assets (In millions)

Changes in assets and liabilities: Accounts payable (In millions)

Changes in assets and liabilities: Accrued payroll and related expenses (In millions)

Changes in assets and liabilities: Income taxes payable (In millions)

Changes in assets and liabilities: Other current and non-current liabilities (In millions)

Net cash provided by (used for) operating activities (In millions)

Acquisitions of property, plant, equipment, investments and intangibles (In millions)

Proceeds from government assistance allocated to fixed assets (In millions)

Purchases of marketable securities (In millions)

Proceeds from sale of marketable securities (In millions)

Other payments (Investing Activities) (In millions)

Net cash used for investing activities (In millions)

Proceeds from issuance of common stock (In millions)

Short-term borrowings, net (In millions)

Revolving credit facility, net (In millions)

Payments on long-term borrowings (In millions)

Payments of tax withholdings related to vesting of stock-based awards (In millions)

Principal payments of deferred consideration (In millions)

Net cash provided by (used for) financing activities (In millions)

Effect of exchange rates on cash (In millions)

Net increase (decrease) in cash, cash equivalents and restricted cash (In millions)

Purchase of property, equipment and intangibles by incurring current liabilities (In millions)

Capital expenditures to be reimbursed under a government contract (In millions)

Transfer of instrument inventories to fixed assets (In millions)

Reduction of accrued payroll and related expenses upon issuance of restricted share units (In millions)

QuidelOrtho Corp (QDEL)

Financials